SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹4.77 Cr | ₹0.42 Cr | ₹1.71 Cr | ₹0.76 Cr | ₹-5.47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SHREE GANESH REMEDIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹4.77 Cr |
Mar2022 | ₹0.42 Cr |
Mar2021 | ₹1.71 Cr |
Mar2020 | ₹0.76 Cr |
Mar2019 | ₹-5.47 Cr |
How is Net Cash Inflow / Outflow of SHREE GANESH REMEDIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹4.77 Cr | 1,043.17 | |
Mar2022 | ₹0.42 Cr | -75.64 | |
Mar2021 | ₹1.71 Cr | 125.26 | |
Mar2020 | ₹0.76 Cr | Positive | |
Mar2019 | ₹-5.47 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹787.5 Cr | -2.3% | -7.3% | 104.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -2.3% |
-7.3% |
104.1% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses